医学
达比加群
胃肠病学
内科学
维生素K拮抗剂
门静脉血栓形成
血栓形成
肝硬化
外科
华法林
心房颤动
作者
Madhumita Premkumar,Harish Bhujade,Prerna Sharma,Jasvinder Nain,Jasmina Ahluwalia,Anchal Sandhu,Yogendra Kumar,Sahaj Rathi,Sunil Taneja,Ajay Duseja,Anand V. Kulkarni,Charanpreet Singh,Shano Naseem,Tanka Karki,Pankaj Gupta,Sreedhara B. Chaluvashetty,Deepesh Lad,K. Rajender Reddy
摘要
On dabigatran, 47% of 119 patients achieved portal vein recanalization over 32 months of follow-up which was higher than the spontaneous RR (21.4%) in an untreated cohort. High Factor VIII:Ag was a predictor of non-recanalization. Dabigatran was safe in cirrhosis (CP-A and B) while further work is needed in CP-C.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
invisight
DW
kaio_escolar
Nole
没毛的鱼
null
Maestro_S
年年有余
fairytaler
v0id
Marciu33
Crssss
无极微光
凌时爱吃零食
含蓄觅山
156485264
Rita
Elsevier大王
lucky
忧心的曼凝
皖公网安备34019202002308
